Trial Profile

Phase IIb study of LiPlaCis in metastatic breast cancer

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 18 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Apr 2023 According to Allarity Therapeutics Media Release, the company conducted the study in collaboration with investigators at hospitals in Denmark, as well as its CRO Smerud Medical Research International AS. The LiPlaCis program is currently licensed to Chosa Oncology AB for further clinical development.
11 Apr 2023 According to Allarity Therapeutics Media Release, the company announced that an abstract on the Companys proprietary DRP Companion Diagnostic for Cisplatin has been accepted for a poster presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
14 Mar 2023 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com